Cazacu et al., 2020 - Google Patents
Quality of life impact of EUS in patients at risk for developing pancreatic cancerCazacu et al., 2020
View HTML- Document ID
- 17392800083827363920
- Author
- Cazacu I
- Chavez A
- Mendoza T
- Qiao W
- Singh B
- Bokhari R
- Saftoiu A
- Lee J
- Weston B
- Stroehlein J
- Kim M
- Katz M
- Maitra A
- McAllister F
- Bhutani M
- Publication year
- Publication venue
- Endoscopic Ultrasound
External Links
Snippet
Methods: Eighty patients with PCL and/or increased genetic or familial risk for PC who had undergone EUS were contacted. Fifty percent of those patients successfully completed the brief profile of mood states (POMS) and the linear analog scale assessment (LASA) QOL …
- 208000008443 Pancreatic Carcinoma 0 title description 60
Classifications
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06F—ELECTRICAL DIGITAL DATA PROCESSING
- G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
- G06F19/30—Medical informatics, i.e. computer-based analysis or dissemination of patient or disease data
- G06F19/34—Computer-assisted medical diagnosis or treatment, e.g. computerised prescription or delivery of medication or diets, computerised local control of medical devices, medical expert systems or telemedicine
- G06F19/345—Medical expert systems, neural networks or other automated diagnosis
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
- G01N33/574—Immunoassay; Biospecific binding assay for cancer
- G01N33/57407—Specifically defined cancers
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06F—ELECTRICAL DIGITAL DATA PROCESSING
- G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
- G06F19/30—Medical informatics, i.e. computer-based analysis or dissemination of patient or disease data
- G06F19/32—Medical data management, e.g. systems or protocols for archival or communication of medical images, computerised patient records or computerised general medical references
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06F—ELECTRICAL DIGITAL DATA PROCESSING
- G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
- G06F19/30—Medical informatics, i.e. computer-based analysis or dissemination of patient or disease data
- G06F19/36—Computer-assisted acquisition of medical data, e.g. computerised clinical trials or questionnaires
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06Q—DATA PROCESSING SYSTEMS OR METHODS, SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL, SUPERVISORY OR FORECASTING PURPOSES; SYSTEMS OR METHODS SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL, SUPERVISORY OR FORECASTING PURPOSES, NOT OTHERWISE PROVIDED FOR
- G06Q50/00—Systems or methods specially adapted for a specific business sector, e.g. utilities or tourism
- G06Q50/10—Services
- G06Q50/22—Health care, e.g. hospitals; Social work
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Detecting, measuring or recording for diagnostic purposes; Identification of persons
- A61B5/41—Detecting, measuring or recording for evaluating the immune or lymphatic systems
- A61B5/414—Evaluating particular organs or parts of the immune or lymphatic systems
- A61B5/415—Evaluating particular organs or parts of the immune or lymphatic systems the glands, e.g. tonsils, adenoids or thymus
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/60—Complex ways of combining multiple protein biomarkers for diagnosis
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Marchegiani et al. | “Trivial” cysts redefine the risk of cancer in presumed branch-duct intraductal papillary mucinous neoplasms of the pancreas: a potential target for follow-up discontinuation? | |
Oba et al. | Prognosis based definition of resectability in pancreatic cancer: a road map to new guidelines | |
Segev et al. | Left-sided dominance of early-onset colorectal cancers: a rationale for screening flexible sigmoidoscopy in the young | |
Adaway et al. | Serum and plasma 5-hydroxyindoleacetic acid as an alternative to 24-h urine 5-hydroxyindoleacetic acid measurement | |
Jurga-Karwacka et al. | A forgotten disease: Pelvic congestion syndrome as a cause of chronic lower abdominal pain | |
Mosk et al. | Low skeletal muscle mass as a risk factor for postoperative delirium in elderly patients undergoing colorectal cancer surgery | |
Miao Jonasson et al. | HbA1C and cancer risk in patients with type 2 diabetes–a nationwide population-based prospective cohort study in Sweden | |
Pearce et al. | A longitudinal study of predictors of sexual dysfunction in men on active surveillance for prostate cancer | |
Cazacu et al. | Psychological impact of pancreatic cancer screening by EUS or magnetic resonance imaging in high-risk individuals: A systematic review | |
Zhi et al. | Low skeletal muscle area as a prognostic marker for chronic obstructive pulmonary disease in elderly patients admitted to ICU | |
Cazacu et al. | Quality of life impact of EUS in patients at risk for developing pancreatic cancer | |
Fastrez et al. | Evaluation of 18FDG PET-CT in the diagnosis of endometriosis: a prospective study | |
Marchegiani et al. | Serous cystic neoplasms of the pancreas management in the real-world: still operating on a benign entity | |
Cavaliere et al. | 1st evidence-based Italian consensus conference on cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinosis from ovarian cancer | |
Carter et al. | The accuracy of intestinal ultrasound compared with small bowel capsule endoscopy in assessment of suspected Crohn’s disease in patients with negative ileocolonoscopy | |
Chen et al. | Analyses of high-risk factors for cervical lymph node metastasis in laryngeal squamous cell carcinoma and establishment of nomogram prediction model | |
Zheng et al. | Combining contrast-enhanced ultrasound and blood cell analysis to improve diagnostic accuracy of plasma cell mastitis | |
Meng et al. | Mesenteric abnormalities play an important role in grading intestinal fibrosis in patients with Crohn’s disease: a computed tomography and clinical marker-based nomogram | |
Ecker et al. | Segmental versus diffuse main duct intraductal papillary mucinous neoplasm: Examination of main pancreatic duct morphology and implications for malignancy risk and extent of surgical resection | |
Karamanos et al. | The relationship between age, common bile duct diameter and diagnostic probability in suspected choledocholithiasis | |
Armstrong et al. | Risk factors for progression in patients undergoing surveillance for pancreatic cysts | |
Schweighauser et al. | Evaluation of endosonography as a new diagnostic tool for feline pancreatitis | |
Loh et al. | A novel CT-emphysema index/FEV1 approach of phenotyping COPD to predict mortality | |
Miniati et al. | Body height as risk factor for emphysema in COPD | |
Goksever Celik et al. | Abdominal wall endometriosis: A monocentric continuous series and review of the literature |